Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-006153
Filing Date
2023-04-04
Accepted
2023-04-04 19:32:02
Documents
1
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form4-04042023_110449.html 4  
1 form4-04042023_110449.xml 4 4252
  Complete submission text file 0001415889-23-006153.txt   5569
Mailing Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500
Business Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500 2246676100
ABBOTT LABORATORIES (Issuer) CIK: 0000001800 (see all company filings)

EIN.: 360698440 | State of Incorp.: IL | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1095 AVENUE OF THE AMERICAS, 8TH FLOOR NEW YORK NY 10036
Business Address
Stratton John G (Reporting) CIK: 0001385262 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-02189 | Film No.: 23800554